24.250
+0,00%
2026-10-19
Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +17.0% | -7.6% | 2 / 3 | -3.8% | +2.30 pp | +6.69 pp | +13.3% | 0.00 | 2.53 | 127 | −3,8% | 42,0 | +20,6% | 2.53 | 14.31 | −82,3% |
| Pts | 0 | 0 | 8 | 0 | 8 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 24.250 (close price on 2026-10-19)EPS (TTM): 9.569
Financial charts
1.Revenue & growth
VND bn127Q2/26
1.Revenue & growth
VND bn127Q2/26
2.Profit & growth
VND bn42,1Q2/26
3.Profit mix (Penman)
VND bn310Q2/26
4.Margins & cost structure
%31.7%Q2/26
5.Returns & cash cycle
% · days9.6%Q2/26
6.Earnings quality & cash
VND bn168Q2/26
7.Asset structure
VND bn2.434Q2/26
8.Funding & debt health
VND bn · times2.434Q2/26
9.Revenue backlog
VND bn62,3Q2/26
10.Valuation
times · %2,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.402Q2/26
Adjusted EPS growth, latest quarter
20.6%
Average adjusted EPS growth, 3 quarters
-4.8%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26